Cadila Healthcare - Convergence of moving averages

111
Another stock along with IPCA which would benefit from the current demand for hydrochloroquine. Marked prices are 2 places where stock can be purchased.

SL below 200EMA.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.